ENTECAVIR 0.5 MG TABLET

ENTECAVIR
$0.2110per EA

Strength

.5 mg/1

Manufacturer

Cipla USA Inc.

NDC

69097042602

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

ENTECAVIR

Approval Type

Generic (ANDA)

FDA Application

ANDA206872

On Market Since

12/6/2016

Pharmacological Classes

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Nucleoside Analog
Nucleoside Reverse Transcriptase Inhibitors

Price History

1W

0.0%

1M

-4.9%

3M

-6.9%

6M

-12.7%

1Y

-28.0%

3Y

-47.2%

5Y

-78.8%

All

-97.6%